Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001060350 | SCV001225031 | uncertain significance | not provided | 2022-04-04 | criteria provided, single submitter | clinical testing | This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 282 of the RBP3 protein (p.Val282Met). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 208298). This variant has not been reported in the literature in individuals affected with RBP3-related conditions. This variant is present in population databases (rs782095820, gnomAD 0.01%). |
Ce |
RCV001060350 | SCV002497028 | uncertain significance | not provided | 2022-01-01 | criteria provided, single submitter | clinical testing | |
Clin |
RCV000206985 | SCV000244043 | uncertain significance | Retinitis pigmentosa 66 | 2013-06-27 | no assertion criteria provided | literature only |